|
RIT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.776170E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.565590E-01 |
| Normal-vs-Stage2 |
5.694600E-01 |
| Normal-vs-Stage3 |
3.099800E-01 |
| Normal-vs-Stage4 |
1.563020E-01 |
| Stage1-vs-Stage2 |
9.822000E-02 |
| Stage1-vs-Stage3 |
9.792400E-01 |
| Stage1-vs-Stage4 |
6.776600E-01 |
| Stage2-vs-Stage3 |
1.597030E-01 |
| Stage2-vs-Stage4 |
8.028200E-02 |
| Stage3-vs-Stage4 |
7.098600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.726750E-01 |
| Normal-vs-AfricanAmerican |
2.889800E-02 |
| Normal-vs-Asian |
1.691780E-01 |
| Caucasian-vs-AfricanAmerican |
8.303600E-02 |
| Caucasian-vs-Asian |
6.992600E-01 |
| AfricanAmerican-vs-Asian |
1.400380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.457970E-01 |
| Normal-vs-Female |
2.550600E-01 |
| Male-vs-Female |
5.117600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.403410E-01 |
| Normal-vs-Age(41-60Yrs) |
4.226600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.286000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.347200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.759200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.372600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.502600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.309400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.746600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.032600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.564200E-03 |
| Classical-VS-Follicular |
3.22590000045864E-07 |
| Classical-VS-Other |
2.025800E-01 |
| Classical-VS-Normal |
4.137200E-03 |
| Tall-VS-Follicular |
3.122000E-01 |
| Tall-VS-Other |
8.805400E-01 |
| Tall-VS-Normal |
6.157400E-01 |
| Follicular-VS-Other |
6.842600E-01 |
| Follicular-VS-Normal |
7.335700E-02 |
| Other-VS-Normal |
6.508600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.149600E-01 |
| Normal-vs-N1 |
4.044800E-01 |
| N0-vs-N1 |
3.036600E-01 |
|
|
